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A B S T R A C T
Background
Measurement of cervical length (CL) by transvaginal ultrasound (TVU) is predictive of preterm birth (PTB). It is unclear if this
screening test is effective for prevention of PTB.
Objectives
To assess the effectiveness of antenatal management based on transvaginal ultrasound of cervical length (TVU CL) screening for
preventing PTB.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (31 August 2012), reviewed the reference lists of all articles
and contacted experts in the field for additional and ongoing trials.
Selection criteria
Published and unpublished randomized controlled trials including pregnant women between the gestational ages of 14 to 32 weeks
screened with TVU CL for risk of PTB. This review focuses exclusively on studies based on knowledge versus no knowledge of TVU
CL results.
Data collection and analysis
All potential studies identified from the search were independently assessed for inclusion by three review authors. We also analyzed
studies for quality measures and extracted data.
Main results
Of the 13 trials identified, five were eligible for inclusion (n = 507). Three included singleton gestations with preterm labor (PTL);
one included singleton gestations with preterm premature rupture of membranes (PPROM); and one included twin gestations with or
without PTL.
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In the three trials of singleton gestations with PTL, 290 women were randomized; 147 to knowledge and 143 to no knowledge of
TVU CL. Knowledge of TVU CL results was associated with a non-significant decrease in PTB at less than 37 weeks (22.3% versus
34.7%, respectively; average risk ratio 0.59, 95% confidence interval (CI) 0.26 to 1.32; two trials, 242 women) and at less than 34
weeks (6.9% verus 12.6%; RR 0.55, 95% CI 0.25 to 1.20; three trials, 256 women). Delivery occurred at a later gestational age in
the knowledge versus no knowledge groups (mean difference (MD) 0.64 weeks, 95% CI 0.03 to 1.25; three trials, 290 women). For
all other outcomes for which there were available data (PTB at less than 34 or 28 weeks; birthweight less than 2500 grams; perinatal
death; maternal hospitalization; tocolysis; and steroids for fetal lung maturity), there was no evidence of a difference between groups.
The trial of singleton gestations with PPROM (n = 92) evaluated as its primary outcome safety of TVU CL in this population, and not
its effect on management. There was no evidence of a difference in incidence of maternal and neonatal infections between the TVU
CL and no TVU CL groups.
In the trial of twin gestations with or without PTL (n = 125), there was no evidence of a difference in PTB at less than 36, 34, or 30
weeks, gestational age at delivery, and other perinatal and maternal outcomes between the TVU CL and the no TVU CL groups. Life-
table analysis revealed significantly less PTB at less than 35 weeks in the TVU CL group compared with the no TVU CL group (P =
0.02).
Authors’ conclusions
Currently, there is insufficient evidence to recommend routine screening of asymptomatic or symptomatic pregnant women with TVU
CL. Since there is a non-significant association between knowledge of TVU CL results and a lower incidence of PTB at less than
37 weeks in symptomatic women, we encourage further research. Future studies should look at specific populations separately (e.g.,
singleton versus twins; symptoms of PTL or no such symptoms), report on all pertinent maternal and perinatal outcomes, and include
cost-effectiveness analyses. Most importantly, future studies should include a clear protocol for management of women based on TVU
CL results, so that it can be easily evaluated and replicated.
P L A I N L A N G U A G E S U M M A R Y
Cervical assessment by ultrasound for preventing preterm delivery
Preterm birth before 37 weeks is the main cause of death and disability for neonates. The lower part of the uterus, called the cervix,
is the opening or passage through which births, including preterm, occur. Ultrasound performed through the vagina can detect early
changes of the cervix that predict preterm birth. This review assessed if knowledge of such changes can prevent preterm birth. Of the 13
trials identified, five (507 women) were eligible for inclusion. Currently, the studies reported are insufficient to recommend ultrasound
of the cervix for prevention of preterm birth. Since there is a tendency for knowledge of the results of the cervical ultrasound to be
associated with a lower chance of preterm birth in women who have uterine contractions and preterm labor, further research should be
encouraged.
B A C K G R O U N D
Description of the condition
Preterm birth (PTB) is defined by the World Health Organiza-
tion as birth between 20 and 36 6/7 weeks. PTB can be sponta-
neous, and follow preterm labor (PTL) (50%), or preterm prema-
ture rupture of membranes (PPROM) (30%). It can also be iatro-
genic (caused by health worker intervention) (20%). Its incidence
is about 5% to 8% in most developed and developing countries.
This incidence is increasing in many countries, including devel-
oping countries, despite extensive research efforts. It was 12.% in
2010 in theUSA , representingmore than 500,000 PTBs annually
in the USA alone (National Vital Statistics Report 2011). Some
of the reasons may include increases in the incidence of multiple
gestations, assisted reproductive technologies, better dating and
recording of gestational age, more fetal monitoring and iatrogenic
deliveries, etc. PTB is the main cause of neonatal morbidity and
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mortality in most countries, especially in developed countries. In
the USA, 75% of perinatal mortality occurs in preterm babies;
60% of total perinatal mortality occurs in infants born before
32 weeks. Mortality and morbidities are inversely associated with
gestational age at birth. Morbidities include respiratory distress
syndrome, bronchopulmonary dysplasia, intraventricular hemor-
rhage, necrotizing enterocolitis, sepsis, retinopathy, etc. Thewhole
family suffers greatly in several aspects when a baby has been born
prematurely, including medically, socially, psychologically, and fi-
nancially.
Description of the intervention
Most of the interventions studied have been aimed at tertiary pre-
vention, i.e., prevention once symptoms (e.g., PTL or PPROM)
develop. Interventions based on risk factors, usually based on prior
history, have generally been unsuccessful. Recently, a screening
test, cervical ultrasound, has been associatedwith better prediction
of PTB than previously available tests, and interventions based on
this screening test have been tested in randomized trials.
How the intervention might work
Cervical assessment by ultrasound has been correlated with the
prediction of spontaneous PTB (Berghella 2003). There are
three methods of ultrasound cervical assessment: transvaginal
(TVU), transabdominal (TA), and transperineal (TP, also called
translabial). The most objective and effective ultrasound method
is transvaginal (TVU) (Hernandez-Andrade 2012). When TA ul-
trasound screening of cervical length (CL) has been compared
with TVU for prediction of PTB, most women detected to
have a short Cl by TVU were not detected by TA ultrasound
(Hernandez-Andrade 2012), so that most literature is the result
of the more predictive TVU screening. The most predictive and
reproducible variable that can be measured on TVU is CL. The
gestational age at which TVU CL is most predictive of PTB is 14
to 34 weeks, but shortening at earlier and later gestational ages is
also associatedwith PTB. The shorter theCL, the higher the risk of
PTB becomes (Grimes-Dennis 2007). The earlier in gestation the
shortening is detected, the higher the risk of PTB (Berghella 2007).
This prediction has been confirmed in all populations screened
with transvaginal ultrasound of cervical length (TVU CL) so far,
including singleton and multiple gestations, women with or with-
out risk factors (e.g., prior PTB, mullerian anomalies, cervical
surgery, etc.) for PTB, asymptomatic women as well as those with
PTL or PPROM (Grimes-Dennis 2007). In fact, TVU CL is one
of the best predictors of PTB in all populations studied so far. The
overall sensitivity and specificity vary according to the CL cut-
off used (e.g., 25 mm versus 15 mm); gestational age at screen-
ing; population studied; prevalence of PTB; single versus serial
screening; etc. Its positive predictive value also varies depending
on the incidence of PTL in the population studied. The interven-
tion of CL assessment by ultrasound has been studied in combina-
tion with other interventions (e.g. cerclage, progesterone, pessary,
etc) for prevention of PTB, and the reader is encouraged to read
these specificCochrane Reviews. (e.g., progesterone (Dodd 2006),
cerclage (Alfirevic 2012; Rafael 2011); or pessary (Abdel-Aleem
2010)).Knowledge of CL assessment by ultrasound per se can also
be considered an intervention, and is the topic of this review. In
addition, CL assessment could also reduce other intervention (e.g.
activity restriction, tocolytics, steroids, etc).
Why it is important to do this review
PTB is the main cause of neonatal morbidity and mortality in
most countries, especially in developed countries. In the USA,
75% of perinatal mortality occurs in preterm babies; 60% of total
perinatal mortality occurs in infants born before 32 weeks. Mor-
tality and morbidities are inversely associated with gestational age
at birth. Morbidities include respiratory distress syndrome, bron-
chopulmonary dysplasia, intraventricular hemorrhage, necrotiz-
ing enterocolitis, sepsis, retinopathy, etc. The whole family suffers
greatly in several aspects when a baby has been born prematurely,
including medically, socially, psychologically, and financially.
O B J E C T I V E S
To assess the effectiveness of antenatal management based on
transvaginal ultrasound cervical length screening for preventing
preterm birth.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Published and unpublished randomized controlled trials. We
planned to include cluster-randomized and quasi-randomized tri-
als, if available.
Types of participants
Pregnant women between the gestational ages of 14 to 34 weeks
screened with transvaginal ultrasound (TVU) and/or transabdom-
inal ultrasound (TA) cervical length (CL) for risk of preterm
birth. Given the different characteristics of singleton versus
twin gestations, women with asymptomatic versus symptomatic
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(preterm labor (PTL) or pretermpremature rupture ofmembranes




• symptomatic singletons with PTL;
• symptomatic singleton with PPROM;
• symptomatic twins with PTL;
• symptomatic twins with PPROM.
The analysis was also divided by the type of CL ultrasound screen-
ing, i.e. TA versus TVU. We carried out analysis of other partici-
pants by type of population, as described under ’subgroup analy-
ses’.
Types of interventions
A screening test such as TVU CL/TA can only be considered
effective if the interventions based on screening results reduce the
outcome of preterm birth. For this review, screening TVUCL/TA
modalities on which interventions were based were:
• knowledge versus no knowledge of TVU CL/TA results
(i.e., TVU CL/TA is performed on all women, but women are
randomized so that in about 50% of them the result is available
to the managing obstetrician, while in about 50% the managing
obstetrician is blind to the TVU CL/TA result); or TVU CL/TA
versus no TVU CL/TA (TVU CL/TA screening is only
performed on half of the women).
Types of outcome measures
Primary outcomes
1. Preterm birth (less than 37 weeks for singleton gestations;
less than 34 weeks for twin gestations)
Secondary outcomes
1. Preterm birth (less than 36 weeks) (outcome not
prespecified)
2. Preterm birth (less than 34 weeks)
3. Preterm birth (less than 30 weeks) (outcome not
prespecified)
4. Preterm birth (less than 32 weeks)
5. Preterm birth (less than 28 weeks)
6. Gestational age at delivery
7. Birthweight less than 2500 grams
8. Birthweight (outcome not prespecified)
9. Composite perinatal outcome (perinatal death, respiratory
distress syndrome, intraventricular hemorrhage, necrotizing
enterocolitis, and sepsis)
10. Perinatal death (fetal death and neonatal death)
11. Fetal death
12. Neonatal death
13. Neonatal infection (outcome not prespecified)




18. Neonatal intensive care unit (NICU) admission
19. NICU days
20. Maternal hospitalization
21. Maternal wellbeing (e.g., stress level, etc)




26. Chorioamnionitis (outcome not prespecified)
27. Endometritis (outcome not prespecified)
Search methods for identification of studies
Electronic searches
We searched the Cochrane Pregnancy and Childbirth Group’s Tri-
als Register by contacting the Trials Search Co-ordinator (31 Au-
gust 2012).
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE;
3. weekly searches of EMBASE;
4. handsearches of 30 journals and the proceedings of major
conferences;
5. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL, MEDLINE and
EMBASE, the list of handsearched journals and conference pro-
ceedings, and the list of journals reviewed via the current aware-
ness service can be found in the ‘Specialized Register’ section
within the editorial information about the Cochrane Pregnancy
and Childbirth Group.
Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
For details of additional searching carried out for the initial version
of the review, please see Appendix 1.
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Searching other resources
We reviewed the reference list of all articles, in particular trials and
review articles. If necessary, we contacted researchers to provide
further information. We contacted experts in the field for addi-
tional and ongoing trials.
We did not apply any language restrictions.
Data collection and analysis
For the methods used when assessing the trials identified in the
previous version of this review, see Appendix 2.
Selection of studies
We assessed for inclusion all potential studies we identified as a
result of the search strategy. Independently, all three review authors
(V Berghella (VB), NHendrix (NH), and JK Baxter (JB)) assessed
all studies for inclusion in the review using the inclusion criteria.
We resolved any disagreement through discussion.
Data extraction and management
We designed a form to extract data. Three authors (VB, NH, JB)
extracted the data using the agreed form.We resolved any disagree-
ment through discussion. We used the Review Manager software
(RevMan 2011) to double enter all the data or a subsample.
When information regarding any of the above was unclear, or to
obtain additional data not published, we attempted to contact
authors of the original reports to provide further details.
Assessment of risk of bias in included studies
We have assessed the validity of each study using the criteria out-
lined in the Cochrane Handbook for Systematic Reviews of Interven-
tions (Higgins 2011).We resolved any disagreement by discussion.
(1) Random sequence generation (checking for possible
selection bias)
We described for each included study the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We have assessed the method as:
• low risk of bias (any truly random process e.g., random
number table; computer random number generator);
• high risk of bias (any non-random process e.g., odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We described for each included study the method used to conceal
allocation to interventions prior to assignment and determined
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g., telephone or central randomization;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
We described for each included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies
were at low risk of bias if they were blinded, or if we judged that
the lack of blinding would be unlikely to affect results.We assessed
blinding separately for different outcomes or classes of outcomes.
We assessed the methods as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We described for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes. We assessed methods used to
blind outcome assessment as:
• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias through withdrawals, dropouts, protocol deviations)
We described for each included study, and for each outcome or
class of outcomes, the completeness of data, including attrition
and exclusions from the analysis. We stated whether attrition and
exclusions were reported, the numbers included in the analysis at
each stage (compared with the total randomized participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information has been reported, or been supplied
by the trial authors, we have re-included missing data in our anal-
yses.
We assessed methods as:
• low risk of bias (less than 20%);
• high risk of bias (greater than or equal to 20%);
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• unclear risk of bias.
(5) Selective reporting bias
We described for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it is clear that all of the study’s
prespecified outcomes and all expected outcomes of interest to
the review have been reported);
• high risk of bias (where not all the study’s prespecified
outcomes have been reported; one or more reported primary
outcomes were not prespecified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
6) Other bias (checking for bias due to problems not
covered by (1) to (5) above)
We described for each included study any important concerns we
had about other possible sources of bias.
We assessed whether each study was free of other problems that
could put it at risk of bias:
• low risk of other bias;
• high risk of other bias;
• unclear whether there is risk of other bias.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria given in the Handbook
(Higgins 2011).With reference to (1) to (6) above, we assessed the
likely magnitude and direction of the bias and whether we consid-
ered it likely to impact on the findings. We planned to explore the
impact of the level of bias through undertaking sensitivity analyses
- see Sensitivity analysis.
Measures of treatment effect
We carried out statistical analysis using the Review Manager soft-
ware (RevMan 2011).We used fixed-effect meta-analysis for com-
bining data in the absence of significant heterogeneity if trials were
sufficiently similar. If heterogeneity was found, we explored this
by sensitivity analysis, followed by random-effects analysis if re-
quired.
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% confidence intervals.
Continuous data
For continuous data, we used the mean difference if outcomes
were measured in the same way between trials. We planned to use
the standardized mean difference to combine trials that measured
the same outcome, but used different methods. If we had found
evidence of skewness, we would have reported this.
Unit of analysis issues
Cluster-randomized trials
We did not identify any cluster-randomized trials for inclusion in
this review, but we may include trials of this type in future up-
dates. If we do, we plan to include cluster-randomized trials in the
analyses along with individually-randomized trials. Their sample
sizes will be adjusted using the methods described in Gates 2005
using an estimate of the intracluster correlation co-efficient (ICC)
derived from the trial (if possible), or from another source. If ICCs
from other sources are used, we will report this and conduct sensi-
tivity analyses to investigate the effect of variation in the ICC. If we
identify both cluster-randomized trials and individually-random-
ized trials, we intend to synthesize the relevant information. We
consider it reasonable to combine the results from both if there is
little heterogeneity between the study designs and the interaction
between the effect of intervention and the choice of randomiza-
tion unit is considered to be unlikely. We will also acknowledged
heterogeneity in the randomization unit and perform a separate
meta-analysis; therefore, the meta-analysis will be performed in
two parts as well if significant heterogeneity is found.
Dealing with missing data
We analyzed data on all participants with available data in the
group to which they were allocated, regardless of whether or not
they received the allocated intervention. If in the original reports
participants were not analyzed in the group to which they were
randomized, and there was sufficient information in the trial re-
port, we attempted to restore them to the correct group.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the T², I² and Chi² statistics. We regarded heterogeneity as sub-
stantial if an I² was greater than 50% and either the T² was greater
than zero, or there was a low P value (less than 0.10) in the Chi²
test for heterogeneity.
Assessment of reporting biases
If 10 or more studies had contributed data to meta-analysis for
any particular outcome, we planned to investigate reporting biases
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(such as publication bias) using funnel plots. We would have as-
sessed possible asymmetry visually, and used formal tests for funnel
plot asymmetry. For continuous outcomes, we would have used
the test proposed by Egger 1997, and for dichotomous outcomes,
we would have used the test proposed by Harbord 2006. If asym-
metry was detected in either of these tests or was suggested by a
visual assessment, we planned to perform exploratory analyses to
investigate it. In this version of the review, insufficient data were
available to allow us to carry out this planned analysis.
Data synthesis
We carried out statistical analysis using the RevMan software (
RevMan 2011). We used fixed-effect meta-analysis for combining
datawhere it was reasonable to assume that studies were estimating
the same underlying treatment effect: i.e., where trials examined
the same intervention, and where we judged the trials’ populations
and methods to be sufficiently similar. If we suspected clinical
heterogeneity sufficient to expect the underlying treatment effects
to differ between trials, or if substantial statistical heterogeneity
was detected, we used random-effects meta-analysis to produce an
overall summary provided that we considered an average treatment
effect across trials was clinically meaningful.
Subgroup analysis and investigation of heterogeneity
We planned the following subgroup analyses classifying whole
trials by interaction tests as described by Deeks 2001:
• women with low-risk singleton gestations versus high-risk
(e.g., prior preterm birth) gestations.
We planned to restrict subgroup analyses to the primary outcomes.
Sensitivity analysis
We planned to carry out sensitivity analyses to explore the effect of
trial quality assessed by concealment of allocation, high attrition
rates, or both, with poor quality studies being excluded from the
analyses in order to assess whether this made any difference to the
overall result.
If quasi-randomized trials are included in future updates, we will
perform a sensitivity analysis by trial quality.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
Our search identified 13 trials, of which five were eligible for inclu-
sion (n = 507). We identified no quasi-randomized trials. All five
included studies used transvaginal ultrasound of cervical length
(TVU CL) for screening, versus either no TVU CL screening, or
no knowledge of results of TVU CL screening. No studies using
transabdominal (TA) ultrasound for cervical length screening were
identified. Therefore, there were also no trials comparing TV ver-
sus TA ultrasound cervical length screening.
Included studies
The five included studies included: no trials on asymptomatic
singletons; one trial on asymptomatic twins without signs and/or
symptoms of preterm labor (PTL) (Gordon 2006); three trials on
symptomatic women with singleton gestations with signs and/or
symptoms of PTL (Alfirevic 2007; Ness 2007; Palacio 2006); one
trial on symptomatic women with singleton gestations with signs
and/or symptoms of preterm premature rupture of membranes
(PPROM) (Carlan 1997); and no trials on symptomatic women
with twin gestations with either PTL or PPROM.
We requested patient-level databases from all authors, and ob-
tained them from one trial (Ness 2007).
In the one trial of symptomatic women with twin gestations with
or without signs and/or symptoms of PTL, the analysis included
63 women who had TVU CL and 62 who did not.
In the three trials of symptomatic womenwith singleton gestations
with signs and/or symptoms of PTL, 290 women were random-
ized; 147were randomized to knowledge and 143 to no knowledge
of TVU CL. These numbers were 145 and 142, respectively, after
exclusion of twin gestations from the Ness trial. Ness 2007 used
knowledge of TVU CL mostly in its protocol for management,
but for women with TVU CL 20 to 29 mm, fetal fibronectin
(FFN) was used to discriminate management, as well.
In the one trial of symptomatic women with singleton gestations
with PPROM, the analysis included 47 women who had TVU
CL and 45 who did not.
Excluded studies
We excluded three trials because they compared history-indi-
cated to ultrasound-indicated cerclage (Beigi 2005; Kassanos
2001; Shennan 2007); one because the TVU CL information was
blinded and not used for management (Matijevic 2006); one be-
cause TVU information was not used for clinical care and no data
on outcomes were provided (Owen 1999); two because they used
transabdominal - not transvaginal - ultrasound (Lorenz 1990; Van
Dijken 1991); and one because it used Cervilenz, which measures
the vaginal part of the cervix rather than CL (Burwick 2011).
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Risk of bias in included studies
See Figure 1 and Figure 2 for summaries of ’Risk of bias’ assess-
ments.
Figure 1. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Risk of selection bias was not present in three studies (Alfirevic
2007; Carlan 1997; Ness 2007). The other two studies (Gordon
2006; Palacio 2006) were reported only as abstracts, with no infor-
mation on methods of randomization or allocation concealment.
Blinding
Risk of performance bias was present in all trials, as participants
and researchers were aware of the arm to which they were random-
ized, but this was inevitable.
In two trials the primary outcomes were objective measures and
so detection bias was assessed as being low risk (Alfirevic 2007;
Gordon 2006). It was unclear in other trials if outcome assessment
had been blinded (Carlan 1997; Ness 2007; Palacio 2006).
Incomplete outcome data
Information regarding an intention-to-treat analysis was available
for three of the five trials. In two trials (Alfirevic 2007; Ness 2007),
all women randomized were included in the intention-to-treat
analysis. In Carlan 1997, one out of 93 (1%) women randomized
was excluded from the analysis because she was delivered immedi-
ately. Attrition bias in terms of loss of data was present in Palacio
2006, since eight out of 157 (5%) women randomized were ex-
cluded from analysis because they were lost to follow-up, and in
Ness 2007, since six out of 100 (6%) women randomized could
not be included in analysis for preterm birth outcomes because
they were lost to follow up. It was not possible to assess incomplete
outcome data in one trial because the trial was only reported as an
abstract and so data were limited (Gordon 2006).
Selective reporting
Risk of reporting bias was unclear in two trials (Gordon 2006;
Palacio 2006) and at low risk of bias in the remaining trials (
Alfirevic 2007; Carlan 1997; Ness 2007).
Other potential sources of bias
Risk of other potential sources of bias was unclear in three trials,
(Carlan 1997; Gordon 2006; Palacio 2006), and at low risk of bias
in the remaining two trials (Carlan 1997; Gordon 2006).
Effects of interventions
TVU CL knowledge versus no knowledge (twins)
In the one trial of twin gestations with or without signs and/or
symptoms of PTL (Gordon 2006), preterm birth less than 36, 34,
32, or 30 weeks, gestational age at delivery, and other perinatal and
maternal outcomes there was no evidence of a difference between
the TVU CL and the no TVU CL groups, (Analysis 1.1; Analysis
1.2; Analysis 1.3; Analysis 1.4; Analysis 1.5; Analysis 1.6; Analysis
1.7; Analysis 1.8; Analysis 1.9). Life table analysis revealed signif-
icantly less preterm birth at less than 35 weeks in the TVU CL
group compared with the no TVU CL group (P = 0.02).
TVU CL knowledge versus no knowledge (singletons
with PTL)
In symptomatic women with singleton gestations with signs and/
or symptoms of PTL, knowledge of TVUCL results was associated
with a non-significant decrease in preterm birth at less than 37
weeks compared with no such knowledge (22.3% versus 34.7%,
respectively; average risk ratio (RR) 0.59, 95% confidence interval
(CI) 0.26 to 1.32; two trials, 242 women; heterogeneity: Tau² =
0.23; Chi² = 2.90, df = 1 (P = 0.09); I² = 66%), Analysis 2.1.
Delivery occurred at a later gestational age in the knowledge versus
no knowledge groups (mean difference (MD) 0.64 weeks, 95%
CI 0.03 to 1.25; three trials, 290 women)), Analysis 2.4. These
results were mostly determined by the Ness 2007 trial, which used
FFN to determine management in women with TVUCL of 20 to
29 mm. Knowledge of TVU CL results was also associated with
a non-significant decrease in preterm birth at less than 34 weeks
compared with no such knowledge (6.9% versus 12.6%; RR 0.55,
95% CI 0.25 to 1.20; three trials, 256 women), Analysis 2.2. All
other outcomes for which there were available data (preterm birth
less than 28 weeks, Analysis 2.3; birthweight less than 2500 grams,
Analysis 2.5; perinatal death, Analysis 2.6; ; tocolysis, Analysis 2.8;
and steroids for fetal lung maturity, Analysis 2.9) were similar in
the two groups. Appropriateness of treatment in terms of steroids
for fetal lung maturity was higher in the knowledge versus the no
knowledge group in the one trial that evaluated this outcome (
Alfirevic 2007).Noothermaternal or fetal outcomeswere available
for meaningful analysis.
Substantial heterogeneity was present in the analyses of preterm
birth at less than 37 weeks, tocolysis, and steroids for fetal lung
maturity (Analysis 2.1; Analysis 2.8; Analysis 2.9).
TVU CL knowledge versus no knowledge (singletons
with PPROM)
The one trial of symptomatic women with singleton gestations
with PPROM (Carlan 1997) evaluated as its primary outcome sa-
fety of TVU CL in this population, and not its effect on manage-
ment. Incidence of PTB or gestational age at delivery were not re-
ported, while there was no evidence of a difference in birthweight
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less than 2500 grams between the two groups, Analysis 3.1. There
was also no evidence of a difference in the incidence of maternal
(20% versus 28%), Analysis 3.2, and neonatal (20% versus 17%)
infections, Analysis 3.4, between the TVU CL and no TVU CL
groups.
Subgroup analysis and sensitivity analysis
Data in the five included trials (Alfirevic 2007; Carlan 1997;
Gordon 2006; Ness 2007; Palacio 2006) were not reported sep-
arately for low-risk versus high-risk (e.g. prior PTB) women, so
that subgroup analysis could not be performed.We did not carry a
sensitivity analysis because most meta-analyses included data from
only one or two studies.
D I S C U S S I O N
Summary of main results
There is limited data on the effect of knowledge of cervical length
by ultrasound for preventing preterm birth (PTB). All trials use
transvaginal ultrasound of cervical length (TVU CL) for screen-
ing, with no trial on transabdominal (TA) ultrasound screening.
There are no trials comparing CL by ultrasound in asymptomatic
women with singleton gestations without preterm labor (PTL) or
preterm premature rupture of membranes (PPROM). The effect
of knowledge of TVU CL in the management of asymptomatic
women with twin gestation without PTL or PPROM cannot be
determined, given that there is just one small trial on this popula-
tion, (Gordon 2006). Knowledge of TVU CL in management of
women with singleton gestations and PTL is not associated with
any significant effects in anymaternal and perinatal outcomes eval-
uated, possibly due to the small number of trials. (Alfirevic 2007;
Ness 2007; Palacio 2006). The effect of knowledge of TVU CL
in the management of symptomatic women with singleton gesta-
tions and PPROM cannot be determined, given that there is just
one small trial on this population.(Carlan 1997) There are also
no trials on symptomatic women with twin gestations with either
PTL or PPROM. There is also very limited evidence on how CL
assessment by ultrasound could avoid unnecessary interventions
(e.g. tocolytics, steroids, etc) in women with a normal CL. Further
research is therefore necessary.
Overall completeness and applicability of
evidence
It is unclear which interventions are most efficacious once TVU
CL results are known. The one study with the most promising
results (Ness 2007) suggested: use of fetal fibronectin (FFN) for
management of women with TVUCL of 20 to 29 mm; a protocol
of no intervention for women with CL equal to or greater than
30 mm; and intervention with steroids for fetal lung maturity and
tocolysis for women with TVU CL less than 20 mm; but these
results need to be replicated before widespread implementation.
Our review did not include, by design, assessment of effectiveness
of interventions based on positive TVU CL screening (short CL),
or negative TVU CL screening (normal or long CL). These are
listed under the specific intervention (e.g., progesterone (Dodd
2006), cerclage (Alfirevic 2012; Rafael 2011); or pessary (Abdel-
Aleem 2010)).
Quality of the evidence
The five included randomized studies were all relatively small.
Blinding was not possible in these five trials. Three of these trials
had a low risk of bias overall.
Potential biases in the review process
One of the authors of this Cochrane Review (Vincenzo Berghella)
is a co-author of one of the included trials (Ness 2007).
Agreements and disagreements with other
studies or reviews
Cervical length may have benefit if associated with a specific in-
tervention. For assessment of effectiveness of interventions based
on positive TVU CL screening (short CL), or negative TVU CL
screening (normal or long CL), please see under the specific in-
tervention (e.g., progesterone, or cerclage). For example, cerclage
performed for a short CL (ultrasound-indicated cerclage) has been
shown to be associated with some benefit (Alfirevic 2012).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Currently, there is insufficient evidence to recommend routine
screening of asymptomatic or symptomatic pregnant women with
TVUCL without a specific intervention. For specific intervention
(e.g., progesterone (Dodd 2006), cerclage (Alfirevic 2012; Rafael
2011); or pessary (Abdel-Aleem 2010)) based on short TVU CL,
please see the relevant Cochrane Reviews.
Implications for research
Since this review found a non-significant association between
knowledge of TVU CL results and a lower incidence of preterm
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birth before 34 and 37 weeks in symptomatic women, the review
authors encourage further research. Future studies should look at
specific populations separately (e.g., singleton versus twins; symp-
toms of PTL or no such symptoms), report on all pertinent mater-
nal and perinatal outcomes, and include cost-effectiveness analy-
ses. Most importantly, future studies should include a clear proto-
col for management of women based on TVU CL results, so that
it can be easily evaluated and replicated.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Alfirevic 2007
Methods RCT.
Participants Singleton gestations; uterine contractions at < 34 weeks; and clinical decision to use
steroids and tocolytics. N = 41
Interventions TVU CL knowledge or not (the control group did not receive TVU CL)
Time TVU CL results available: not specified.
Protocol for TVU knowledge group: yes.
Outcomes Primary: incidence of women still pregnant at 7 days.
Notes Intention-to-treat; only singletons; protocol for management of TVU CL group
Short TVU CL (< 15 mm): 7/21 (33%) in knowledge group; not done in other group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomization.
Allocation concealment (selection bias) Low risk Consecutively numbered sealed envelopes.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and physicians knew which group was randomized to
’knowledge’ or ’no knowledge’
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Some blinding attempted - “Women allocated to the experimen-
tal group had a transvaginal scan to measure the cervical length,
which was performed by a member of the research team who
was not involved in the care of the patient” - but the control
group did not have a transvaginal scan
Primary outcome - is an objective outcome (delivery within 7
days)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No incomplete outcomes. Intention-to-treat analysis.
Selective reporting (reporting bias) Low risk Primary outcome was delivery within 7 days. All other outcomes
reported
Other bias Low risk Baseline characteristics similar.
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Carlan 1997
Methods RCT.
Participants Singleton gestations; PPROM; 24 to 34 weeks. N = 92.
Interventions TVU CL or not (the control group did not receive TVU CL).
Time TVU CL results available: not specified.
Protocol for TVU knowledge group: no.
Outcomes Primary: maternal infection.
Notes Intention-to-treat; only singletons; PPROM; no protocol (really a safety study for TVU
CL in PPROM women)
Short TVU CL (< 25 mm): 14/45 (31%) in knowledge group; not done in other group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomly-generated assignment.”
Allocation concealment (selection bias) Low risk “Randomly-generated” assignments in sealed envelopes.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study group had weekly US while controls had none.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1% explained.
Selective reporting (reporting bias) Low risk Primary outcome was chorioamnionitis. All other outcomes re-
ported
Other bias Unclear risk No baseline characteristics table.
Gordon 2006
Methods RCT.
Participants Twin gestations; asymptomatic and with PTL symptoms; 15 to 34 weeks. N = 125
Interventions TVU CL screening at 15 to 28 weeks, and if PTL symptoms develop or not (the control
group did not receive TVU CL)
Time TVU CL results available: not specified.
Protocol for TVU knowledge group: yes.
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Gordon 2006 (Continued)
Outcomes Primary: length of gestation.
Notes Only abstract published; unclear if intention-to-treat; only twins; protocol for manage-
ment of TVU CL group
Short TVU CL not available.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomization not described.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Different protocols for study and control groups.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Primary outcome objective - length of gestation.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No incomplete outcomes mentioned.
Selective reporting (reporting bias) Unclear risk Primary outcome was gestational age at delivery.
Other bias Unclear risk Abstract only, so data reported are limited.
Ness 2007
Methods RCT.
Participants Singleton (and 3 twin) gestations; uterine contractions or symptoms suggestive of PTL
at 24 to 33 6/7 weeks. N = 100
Interventions TVU CL knowledge or not (the control group did receive TVU CL, but results were
blinded to managing physicians)
Time TVU CL results available: not specified.
Protocol for TVU knowledge group: yes.
Outcomes Primary: time from initial evaluation to discharge.
Notes Intention to treat; 97% singletons; protocol for management of TVU CL group, which
included management based on FFN for women with CL 20 to 29 mm
Short TVUCL (< 20mm): 11/51 (22%) in knowledge group; 7/49 (15%) in the control
group
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Ness 2007 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers.
Allocation concealment (selection bias) Low risk Numbered, sealed opaque envelopes.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and physicians knew which group was randomized to
’knowledge’ or ’no knowledge’
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat analyses.
Selective reporting (reporting bias) Low risk Primary outcome time from evaluation to discharge. All other
outcomes reported
Other bias Low risk Baseline characteristics similar.
Palacio 2006
Methods RCT.
Participants Singleton gestations; PTL at 24 to 35 6/7 weeks. N = 149.
Interventions TVU CL knowledge or not (the control group did receive TVU CL, but results were
blinded to managing physicians)
Time TVU CL results available: not specified.
Protocol for TVU knowledge group: yes.
Outcomes Primary: hospital length of stay.
Notes Only abstract published; 7 women lost to follow up; only singletons; protocol for man-
agement of TVU CL group
Short TVU CL (< 25 mm): 22/75 (29%) in knowledge group; 20/74 (27%) in the
control group
Risk of bias
Bias Authors’ judgement Support for judgement
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Palacio 2006 (Continued)
Random sequence generation (selection
bias)
Unclear risk Randomization not described.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and physicians knew which group was randomized to
’knowledge’ or ’no knowledge’
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk 5% of data removed from final analysis.
Selective reporting (reporting bias) Unclear risk Length of hospital stay primary outcome.
Other bias Unclear risk Abstract only. Data limited.
CL: cervical length
FFN: fetal fibronectin
PPROM: preterm premature rupture of membranes
PTL: preterm labor
RCT: randomized controlled trial
TVU: transvaginal ultrasound
US: ultrasound
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Beigi 2005 Compared history-indicated to ultrasound-indicated cerclage.
Burwick 2011 Used Cervilenz, which is a plastic instrument to measure the vaginal part of the cervix. This is outside the scope
of our review, which focuses on CL measured exclusively by TVU
Kassanos 2001 Compared history-indicated to ultrasound-indicated cerclage.
Lorenz 1990 Control group was not ’no ultrasound’ or ’no knowledge’, but was manual digital cervical exam. Interestingly,
the study group utilized transabdominal ultrasound
Matijevic 2006 The TVU CL information was blinded and not used for management
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(Continued)
Owen 1999 TVU information was not used for clinical care and no data on outcomes were provided
Shennan 2007 Compared history-indicated to ultrasound-indicated cerclage.
Van Dijken 1991 Control group was not ’no ultrasound’ or ’no knowledge’, but was manual digital cervical exam. Interestingly,
the study group utilized transabdominal - not TVU
CL: cervical length
TVU: transvaginal ultrasound
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D A T A A N D A N A L Y S E S
Comparison 1. TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or PPROM)




participants Statistical method Effect size
1 Preterm birth < 36 weeks 1 125 Risk Ratio (M-H, Fixed, 95% CI) 1.27 [0.85, 1.90]
2 Preterm birth < 34 weeks 1 125 Risk Ratio (M-H, Fixed, 95% CI) 0.62 [0.30, 1.25]
3 Preterm birth < 32 weeks 1 125 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.17, 1.83]
4 Preterm birth < 30 weeks 1 125 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.02, 1.64]
5 Gestational age at delivery 1 125 Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.74, 1.14]
6 Birthweight 1 125 Mean Difference (IV, Fixed, 95% CI) 155.0 [-57.61, 367.
61]
7 Maternal hospitalization (PTL) 1 125 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [0.75, 2.23]
8 Tocolysis 1 125 Risk Ratio (M-H, Fixed, 95% CI) 1.34 [0.74, 2.42]
9 Steroids for fetal lung maturity 1 125 Risk Ratio (M-H, Fixed, 95% CI) 0.79 [0.49, 1.26]
Comparison 2. TVU CL knowledge versus no knowledge (symptomatic singletons with PTL)




participants Statistical method Effect size
1 Preterm birth < 37 weeks 2 242 Risk Ratio (M-H, Random, 95% CI) 0.59 [0.26, 1.32]
2 Preterm birth < 34 weeks 3 256 Risk Ratio (M-H, Fixed, 95% CI) 0.55 [0.25, 1.20]
3 Preterm birth < 28 weeks 2 137 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 gestational age at delivery 3 290 Mean Difference (IV, Fixed, 95% CI) 0.64 [0.03, 1.25]
5 Birthweight < 2500 grams 1 70 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.21, 2.44]
6 Perinatal death 1 97 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Maternal hospitalization 1 93 Risk Ratio (M-H, Fixed, 95% CI) 2.94 [0.85, 10.16]
8 Tocolysis 2 102 Risk Ratio (M-H, Random, 95% CI) 0.85 [0.11, 6.58]
9 Steroids for fetal lung maturity 2 114 Risk Ratio (M-H, Random, 95% CI) 1.72 [0.15, 19.64]
Comparison 3. TVU CL knowledge versus no knowledge (symptomatic singletons with PPROM)




participants Statistical method Effect size
1 Birthweight < 2500 grams 1 92 Mean Difference (IV, Fixed, 95% CI) 31.0 [-162.16, 224.
16]
2 Chorioamnionitis 1 92 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.34, 1.52]
3 Endometritis 1 92 Risk Ratio (M-H, Fixed, 95% CI) 1.39 [0.33, 5.88]
4 Neonatal infection 1 92 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.50, 2.78]
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Analysis 1.1. Comparison 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or
PPROM), Outcome 1 Preterm birth < 36 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or PPROM)
Outcome: 1 Preterm birth < 36 weeks
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2006 31/63 24/62 100.0 % 1.27 [ 0.85, 1.90 ]
Total (95% CI) 63 62 100.0 % 1.27 [ 0.85, 1.90 ]
Total events: 31 (Experimental), 24 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.17 (P = 0.24)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
Analysis 1.2. Comparison 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or
PPROM), Outcome 2 Preterm birth < 34 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or PPROM)
Outcome: 2 Preterm birth < 34 weeks
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2006 10/63 16/62 100.0 % 0.62 [ 0.30, 1.25 ]
Total (95% CI) 63 62 100.0 % 0.62 [ 0.30, 1.25 ]
Total events: 10 (Experimental), 16 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.35 (P = 0.18)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 1.3. Comparison 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or
PPROM), Outcome 3 Preterm birth < 32 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or PPROM)
Outcome: 3 Preterm birth < 32 weeks
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2006 4/63 7/62 100.0 % 0.56 [ 0.17, 1.83 ]
Total (95% CI) 63 62 100.0 % 0.56 [ 0.17, 1.83 ]
Total events: 4 (Experimental), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.96 (P = 0.34)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
Analysis 1.4. Comparison 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or
PPROM), Outcome 4 Preterm birth < 30 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or PPROM)
Outcome: 4 Preterm birth < 30 weeks
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2006 1/63 5/62 100.0 % 0.20 [ 0.02, 1.64 ]
Total (95% CI) 63 62 100.0 % 0.20 [ 0.02, 1.64 ]
Total events: 1 (Experimental), 5 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 1.5. Comparison 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or
PPROM), Outcome 5 Gestational age at delivery.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or PPROM)
Outcome: 5 Gestational age at delivery





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Gordon 2006 63 35.7 (2.2) 62 35.5 (3.1) 100.0 % 0.20 [ -0.74, 1.14 ]
Total (95% CI) 63 62 100.0 % 0.20 [ -0.74, 1.14 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.68)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
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Analysis 1.6. Comparison 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or
PPROM), Outcome 6 Birthweight.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or PPROM)
Outcome: 6 Birthweight





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Gordon 2006 63 2496 (525) 62 2341 (677) 100.0 % 155.00 [ -57.61, 367.61 ]
Total (95% CI) 63 62 100.0 % 155.00 [ -57.61, 367.61 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.43 (P = 0.15)
Test for subgroup differences: Not applicable
-200 -100 0 100 200
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Analysis 1.7. Comparison 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or
PPROM), Outcome 7 Maternal hospitalization (PTL).
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or PPROM)
Outcome: 7 Maternal hospitalization (PTL)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2006 21/63 16/62 100.0 % 1.29 [ 0.75, 2.23 ]
Total (95% CI) 63 62 100.0 % 1.29 [ 0.75, 2.23 ]
Total events: 21 (Experimental), 16 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
Analysis 1.8. Comparison 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or
PPROM), Outcome 8 Tocolysis.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or PPROM)
Outcome: 8 Tocolysis
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2006 19/63 14/62 100.0 % 1.34 [ 0.74, 2.42 ]
Total (95% CI) 63 62 100.0 % 1.34 [ 0.74, 2.42 ]
Total events: 19 (Experimental), 14 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 1.9. Comparison 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or
PPROM), Outcome 9 Steroids for fetal lung maturity.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 TVU CL knowledge versus no knowledge (asymptomatic twins without PTL or PPROM)
Outcome: 9 Steroids for fetal lung maturity
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2006 20/63 25/62 100.0 % 0.79 [ 0.49, 1.26 ]
Total (95% CI) 63 62 100.0 % 0.79 [ 0.49, 1.26 ]
Total events: 20 (Experimental), 25 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
Analysis 2.1. Comparison 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL),
Outcome 1 Preterm birth < 37 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL)
Outcome: 1 Preterm birth < 37 weeks
Study or subgroup TVU CL knowledge
No TVU CL








Ness 2007 6/46 17/47 41.4 % 0.36 [ 0.16, 0.83 ]
Palacio 2006 21/75 25/74 58.6 % 0.83 [ 0.51, 1.34 ]
Total (95% CI) 121 121 100.0 % 0.59 [ 0.26, 1.32 ]
Total events: 27 (TVU CL knowledge), 42 (No TVU CL knowledge)
Heterogeneity: Tau2 = 0.23; Chi2 = 2.90, df = 1 (P = 0.09); I2 =66%
Test for overall effect: Z = 1.29 (P = 0.20)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 2.2. Comparison 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL),
Outcome 2 Preterm birth < 34 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL)
Outcome: 2 Preterm birth < 34 weeks
Study or subgroup TVU CL knowledge
No TVU CL
knowledge Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Alfirevic 2007 2/21 3/20 19.0 % 0.63 [ 0.12, 3.41 ]
Ness 2007 3/49 6/48 37.6 % 0.49 [ 0.13, 1.85 ]
Palacio 2006 4/59 7/59 43.4 % 0.57 [ 0.18, 1.85 ]
Total (95% CI) 129 127 100.0 % 0.55 [ 0.25, 1.20 ]
Total events: 9 (TVU CL knowledge), 16 (No TVU CL knowledge)
Heterogeneity: Chi2 = 0.06, df = 2 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 1.49 (P = 0.14)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 2.3. Comparison 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL),
Outcome 3 Preterm birth < 28 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL)
Outcome: 3 Preterm birth < 28 weeks
Study or subgroup TVU CL knowledge
No TVU CL
knowledge Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Alfirevic 2007 0/21 0/20 0.0 [ 0.0, 0.0 ]
Ness 2007 0/48 0/48 0.0 [ 0.0, 0.0 ]
Total (95% CI) 69 68 0.0 [ 0.0, 0.0 ]
Total events: 0 (TVU CL knowledge), 0 (No TVU CL knowledge)
Heterogeneity: Chi2 = 0.0, df = 0 (P<0.00001); I2 =0.0%
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL),
Outcome 4 gestational age at delivery.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL)
Outcome: 4 gestational age at delivery







N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Alfirevic 2007 21 37.9 (3) 20 37.6 (2.9) 11.4 % 0.30 [ -1.51, 2.11 ]
Ness 2007 51 38.3 (2.1) 49 37.1 (2.9) 37.4 % 1.20 [ 0.20, 2.20 ]
Palacio 2006 75 37.6 (2.6) 74 37.3 (2.7) 51.2 % 0.30 [ -0.55, 1.15 ]
Total (95% CI) 147 143 100.0 % 0.64 [ 0.03, 1.25 ]
Heterogeneity: Chi2 = 1.96, df = 2 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 2.05 (P = 0.040)
Test for subgroup differences: Not applicable
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Analysis 2.5. Comparison 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL),
Outcome 5 Birthweight < 2500 grams.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL)
Outcome: 5 Birthweight < 2500 grams
Study or subgroup TVU CL knowledge
No TVU CL
knowledge Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ness 2007 4/37 5/33 100.0 % 0.71 [ 0.21, 2.44 ]
Total (95% CI) 37 33 100.0 % 0.71 [ 0.21, 2.44 ]
Total events: 4 (TVU CL knowledge), 5 (No TVU CL knowledge)
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL),
Outcome 6 Perinatal death.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL)
Outcome: 6 Perinatal death
Study or subgroup TVU CL knowledge
No TVU CL
knowledge Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ness 2007 0/49 0/48 0.0 [ 0.0, 0.0 ]
Total (95% CI) 49 48 0.0 [ 0.0, 0.0 ]
Total events: 0 (TVU CL knowledge), 0 (No TVU CL knowledge)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL),
Outcome 7 Maternal hospitalization.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL)
Outcome: 7 Maternal hospitalization
Study or subgroup TVU CL knowledge
No TVU CL
knowledge Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ness 2007 9/47 3/46 100.0 % 2.94 [ 0.85, 10.16 ]
Total (95% CI) 47 46 100.0 % 2.94 [ 0.85, 10.16 ]
Total events: 9 (TVU CL knowledge), 3 (No TVU CL knowledge)
Heterogeneity: not applicable
Test for overall effect: Z = 1.70 (P = 0.089)
Test for subgroup differences: Not applicable
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Analysis 2.8. Comparison 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL),
Outcome 8 Tocolysis.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL)
Outcome: 8 Tocolysis
Study or subgroup TVU CL knowledge
No TVU CL








Alfirevic 2007 7/21 20/20 55.1 % 0.35 [ 0.19, 0.63 ]
Ness 2007 9/39 2/22 44.9 % 2.54 [ 0.60, 10.72 ]
Total (95% CI) 60 42 100.0 % 0.85 [ 0.11, 6.58 ]
Total events: 16 (TVU CL knowledge), 22 (No TVU CL knowledge)
Heterogeneity: Tau2 = 1.89; Chi2 = 7.00, df = 1 (P = 0.01); I2 =86%
Test for overall effect: Z = 0.16 (P = 0.88)
Test for subgroup differences: Not applicable
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Analysis 2.9. Comparison 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL),
Outcome 9 Steroids for fetal lung maturity.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 TVU CL knowledge versus no knowledge (symptomatic singletons with PTL)
Outcome: 9 Steroids for fetal lung maturity
Study or subgroup TVU CL knowledge
No TVU CL








Alfirevic 2007 18/21 20/20 54.4 % 0.86 [ 0.71, 1.05 ]
Ness 2007 9/39 2/34 45.6 % 3.92 [ 0.91, 16.92 ]
Total (95% CI) 60 54 100.0 % 1.72 [ 0.15, 19.64 ]
Total events: 27 (TVU CL knowledge), 22 (No TVU CL knowledge)
Heterogeneity: Tau2 = 2.83; Chi2 = 11.00, df = 1 (P = 0.00091); I2 =91%
Test for overall effect: Z = 0.44 (P = 0.66)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 TVU CL knowledge versus no knowledge (symptomatic singletons with
PPROM), Outcome 1 Birthweight < 2500 grams.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 3 TVU CL knowledge versus no knowledge (symptomatic singletons with PPROM)
Outcome: 1 Birthweight < 2500 grams





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Carlan 1997 45 1617 (500) 47 1586 (442) 100.0 % 31.00 [ -162.16, 224.16 ]
Total (95% CI) 45 47 100.0 % 31.00 [ -162.16, 224.16 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.75)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 TVU CL knowledge versus no knowledge (symptomatic singletons with
PPROM), Outcome 2 Chorioamnionitis.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 3 TVU CL knowledge versus no knowledge (symptomatic singletons with PPROM)
Outcome: 2 Chorioamnionitis
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Carlan 1997 9/45 13/47 100.0 % 0.72 [ 0.34, 1.52 ]
Total (95% CI) 45 47 100.0 % 0.72 [ 0.34, 1.52 ]
Total events: 9 (Experimental), 13 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.85 (P = 0.39)
Test for subgroup differences: Not applicable
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Analysis 3.3. Comparison 3 TVU CL knowledge versus no knowledge (symptomatic singletons with
PPROM), Outcome 3 Endometritis.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 3 TVU CL knowledge versus no knowledge (symptomatic singletons with PPROM)
Outcome: 3 Endometritis
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Carlan 1997 4/45 3/47 100.0 % 1.39 [ 0.33, 5.88 ]
Total (95% CI) 45 47 100.0 % 1.39 [ 0.33, 5.88 ]
Total events: 4 (Experimental), 3 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.45 (P = 0.65)
Test for subgroup differences: Not applicable
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Analysis 3.4. Comparison 3 TVU CL knowledge versus no knowledge (symptomatic singletons with
PPROM), Outcome 4 Neonatal infection.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 3 TVU CL knowledge versus no knowledge (symptomatic singletons with PPROM)
Outcome: 4 Neonatal infection
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Carlan 1997 9/45 8/47 100.0 % 1.18 [ 0.50, 2.78 ]
Total (95% CI) 45 47 100.0 % 1.18 [ 0.50, 2.78 ]
Total events: 9 (Experimental), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.37 (P = 0.71)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
Authors searched MEDLINE (January 1966 to September 2008)
1 exp Ultrasonography, Prenatal/
2 (cervix or cervical or transvaginal$ or trans-vaginal$).mp.
3 exp Obstetric Labor, Premature/
4 1 and 2 and 3
Appendix 2. Methods used when assessing the trials identified in the previous version of this review
Selection of studies
We assessed for inclusion all potential studies we identified as a result of the search strategy. Independently, all three review authors (V
Berghella (VB), N Hendrix (NH), and JK Baxter (JB)) assessed all studies for inclusion in the review using the inclusion criteria. We
resolved any disagreement through discussion.
Data extraction and management
Wedesigned a form to extract data. Three authors (VB,NH, JB) extracted the data using the agreed form.We resolved any disagreement
through discussion. We used the Review Manager software (RevMan 2008) to double enter all the data or a subsample.
When information regarding any of the above was unclear, or to obtain additional data not published, we attempted to contact authors
of the original reports to provide further details.
Assessment of risk of bias in included studies
We have assessed the validity of each study using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2008). We described the methods used for generation of the randomization sequence for each trial.
(1) Sequence generation (checking for possible selection bias)
Wehave described for each included study themethod used to generate the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We have assessed the method as:
• adequate (any truly random process e.g. random number table; computer random number generator);
• inadequate (any non-random process e.g. odd or even date of birth; hospital or clinic record number);
• unclear.
(2) Allocation concealment (checking for possible selection bias)
We described for each included study the method used to conceal the allocation sequence in sufficient detail and determined whether
intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.
We assessed the methods as:
• adequate (e.g. telephone or central randomization; consecutively numbered sealed opaque envelopes);
• inadequate (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);
• unclear.
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(3) Blinding (checking for possible performance bias)
We have described for each included study the methods used, if any, to blind study participants and personnel from knowledge of
which intervention a participant received. We have judged studies to be at low risk of bias if they were blinded, or if we judged that the
lack of blinding could not have affected the results. We have assessed blinding separately for different outcomes or classes of outcomes.
We have assessed the methods as:
• adequate, inadequate, or unclear for participants;
• adequate, inadequate, or unclear for personnel;
• adequate, inadequate, or unclear for outcome assessors.
(4) Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations)
We have described for each included study, and for each outcome or class of outcomes, the completeness of data, including attrition
and exclusions from the analysis. We have stated whether attrition and exclusions were reported, the numbers included in the analysis
at each stage (compared with the total randomized participants), reasons for attrition or exclusion where reported, and whether missing
data were balanced across groups or were related to outcomes. Where sufficient information has been reported, or been supplied by the
trial authors, we have re-included missing data in our analyses. We have assessed methods as:
• adequate (< 20%);
• inadequate (>= 20%);
• unclear.
(5) Selective reporting bias
We have described for each included study how we investigated the possibility of selective outcome reporting bias and what we found.
We have assessed the methods as:
• adequate (where it is clear that all of the study’s prespecified outcomes and all expected outcomes of interest to the review have
been reported);
• inadequate (where not all the study’s prespecified outcomes have been reported; one or more reported primary outcomes were
not prespecified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome
that would have been expected to have been reported);
• unclear
WH A T ’ S N E W
Last assessed as up-to-date: 28 November 2012.
Date Event Description
28 January 2013 Amended Information added on attrition bias for one study (Ness 2007).
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H I S T O R Y
Protocol first published: Issue 3, 2008
Review first published: Issue 3, 2009
Date Event Description
26 September 2012 New citation required but conclusions have not
changed
Review updated.
26 September 2012 New search has been performed Two studies identified from an updated search have
been assessed for eligibility and both have been ex-
cluded. Methods have been updated
27 January 2012 Amended Search updated. Two trial reports added to Studies
awaiting classification (Burwick 2011; Simcox 2009).
C O N T R I B U T I O N S O F A U T H O R S
Vincenzo Berghella devised the idea, applied for the review, wrote the draft of the review and approved the final edition. Jason K Baxter,
Nancy Hendrix edited and approved the final review, and performed review and analysis of pertinent and included studies.
D E C L A R A T I O N S O F I N T E R E S T
One of the authors of this Cochrane Review (Vincenzo Berghella) is a co-author on one of the included trials (Ness 2007).
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
A number of outcomes not prespecified in the protocol were included in the review, as listed below.
1. Preterm birth (less than 36 weeks) (outcome not prespecified)
2. Preterm birth (less than 30 weeks) (outcome not prespecified)
3. Birthweight (outcome not prespecified)
4. Neonatal infection (outcome not prespecified)
5. Chorioamnionitis (outcome not prespecified)
6. Endometritis (outcome not prespecified)
I N D E X T E R M S
Medical Subject Headings (MeSH)
Cervical Length Measurement [∗methods]; Cervix Uteri [∗ultrasonography]; Pregnancy, Multiple; Pregnancy, Twin; Premature Birth
[∗prevention & control; ultrasonography]; Randomized Controlled Trials as Topic
MeSH check words
Female; Humans; Pregnancy
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